A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.
Some experts said the popularity for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Content Removal
Based on the social media company, the service has removed problematic material and banned associated keywords and search suggestions. The company stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Online Trading Operations
Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at home.
After moments of entering one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Details and Pricing
Inside these groups, messages show black plastic packages with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A representative for the messaging service said it actively moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to potentially serious health risks”.
